<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Anthera Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals
    Invest Now

    About Anthera Pharmaceuticals, Inc.

    Anthera Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on developing and commercializing therapeutics to treat diseases associated with inflammation, including cardiovascular and autoimmune diseases.

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      Start Engine
    • RAISED AMOUNT
      $65,500,000
    • PRE-MONEY EVAULATION
      $8,811,000.00
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Paul F. Truex
    • FOUNDED
      2004
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc.

    Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to im...

    Five Prime Therapeutics, Inc. discovers and dev...

    Filing Type:    PU
    Precipio, Inc.

    Precipio, Inc.

    Precipio has built a platform designed to eradicate the problem of misdiagnosis by...

    Precipio has built a platform designed to eradi...

    Filing Type:    PU
    ENDRA Life Sciences Inc.

    ENDRA Life Sciences Inc.

    ENDRA Life Sciences' mission is to bring new capabilities to ultrasound and broade...

    ENDRA Life Sciences' mission is to bring new ca...

    Filing Type:    PU
    Juhi LLC

    Juhi LLC

    The Juhi Ash Center, located on Fifth Avenue and 61st Street, combines the best of...

    The Juhi Ash Center, located on Fifth Avenue an...

    Amount Raised:    $796,100.00
    Fundraising Status:    SD
    Filing Type:    CF
    Editas Medicine, Inc.

    Editas Medicine, Inc.

    As a leading genome editing company, Editas Medicine is focused on translating the...

    As a leading genome editing company, Editas Med...

    Filing Type:    PU
    Epizyme, Inc.

    Epizyme, Inc.

    Epizyme, Inc. is a clinical stage biopharmaceutical company creating novel epigene...

    Epizyme, Inc. is a clinical stage biopharmaceut...

    Filing Type:    PU
    MediWound Ltd.

    MediWound Ltd.

    MediWound is a fully integrated biopharmaceutical company focused on developing, m...

    MediWound is a fully integrated biopharmaceutic...

    Filing Type:    PU
    ANI Pharmaceuticals, Inc.

    ANI Pharmaceuticals, Inc.

    An emerging leader in the specialty pharmaceuticals industry, ANI Pharmaceuticals ...

    An emerging leader in the specialty pharmaceuti...

    Filing Type:    PU
    Gemphire Therapeutics Inc.

    Gemphire Therapeutics Inc.

    Gemphire Therapeutics Inc. (NASDAQ:GEMP) is a clinical‑stage biopharmaceutical c...

    Gemphire Therapeutics Inc. (NASDAQ:GEMP) is a c...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.